Magnesium deprivation inhibits a MEK-ERK cascade and cell proliferation in renal epithelial Madin-Darby canine kidney cells

Life Sciences

Volumn 86, Issue 19-20, 2010, Pages 766-773

  Ikari, Akira ^a   Atomi, Kosuke ^a   Kinjo, Keishi ^a   Sasaki, Yohei ^a   Sugatani, Junko ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

ERK1 2; Magnesium, cell proliferation, phosphorylation, kidney

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; FLUORESCENT DYE; FURAPTRA; GLUTATHIONE TRANSFERASE; LIPOCORTIN 5; MAGNESIUM ION; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PROPIDIUM IODIDE; PROTEIN WST 1; UNCLASSIFIED DRUG; MAGNESIUM; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME BINDING; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXPERIMENTAL DOG; FETAL CALF SERUM; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; KIDNEY EPITHELIUM; MAGNESIUM DEFICIENCY; NONHUMAN; STAINING; ANIMAL; CATTLE; CELL LINE; CYTOLOGY; DOG; FETUS BLOOD; KIDNEY; METABOLISM; PHOSPHORYLATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CATTLE; CELL LINE; CELL PROLIFERATION; DOGS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FETAL BLOOD; KIDNEY; MAGNESIUM; MAGNESIUM DEFICIENCY; MAP KINASE KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION;

EID: 77951914216     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.03.016     Document Type: Article

References (43)

1. Alexandridis G., Liberopoulos E., Elisaf M. Aminoglycoside-induced reversible tubular dysfunction. Pharmacology 2003, 67(3):118-120.
2. Bae D., Ceryak S. Raf-independent, PP2A-dependent MEK activation in response to ERK silencing. Biochemical and Biophysical Research Communications 2009, 385(4):523-527.
3. Banai S., Haggroth L., Epstein S.E., Casscells W. Influence of extracellular magnesium on capillary endothelial cell proliferation and migration. Circulation Research 1990, 67(3):645-650.
4. Bernardini D., Nasulewic A., Mazur A., Maier J.A. Magnesium and microvascular endothelial cells: a role in inflammation and angiogenesis. Frontiers in Bioscience 2005, 10:1177-1182.
5. ++. Journal of Membrane Biology 2000, 177(2):159-168.
6. Brunet A., Pages G., Pouyssegur J. Growth factor-stimulated MAP kinase induces rapid retrophosphorylation and inhibition of MAP kinase kinase (MEK1). FEBS Letters 1994, 346(2-3):299-303.
7. 2+ ions. Nephrology, Dialysis, Transplantation 2003, 18(11):2262-2268.
8. Cole D.E., Quamme G.A. Inherited disorders of renal magnesium handling. Journal of the American Society of Nephrology 2000, 11(10):1937-1947.
9. Kip1 in human leukemic HL-60 cells. Journal of Cellular Biochemistry 1998, 70(3):313-322.
10. De Araujo M., Andrade L., Coimbra T.M., Rodrigues A.C., Seguro A.C. Magnesium supplementation combined with N-acetylcysteine protects against postischemic acute renal failure. Journal of the American Society of Nephrology 2005, 16(11):3339-3349.
11. Dickens B.F., Weglicki W.B., Li Y.S., Mak I.T. Magnesium deficiency in vitro enhances free radical-induced intracellular oxidation and cytotoxicity in endothelial cells. FEBS Letters 1992, 311(3):187-191.
12. Doctor R.B., Bacallao R., Mandel L.J. Method for recovering ATP content and mitochondrial function after chemical anoxia in renal cell cultures. American Journal of Physiology 1994, 266(6 Pt 1):C1803-C1811.
13. Fukuda M., Gotoh Y., Nishida E. Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase. EMBO Journal 1997, 16(8):1901-1908.
14. Gekle M., Freudinger R., Mildenberger S., Silbernagl S. Aldosterone interaction with epidermal growth factor receptor signaling in MDCK cells. American Journal of Physiology. Renal Physiology 2002, 282(4):F669-F679.
15. 2+ indicators with greatly improved fluorescence properties. Journal of Biological Chemistry 1985, 260(6):3440-3450.
16. 2+ transport in renal epithelial cells. Biochemical and Biophysical Research Communications 2001, 287(3):671-674.
17. Ikari A., Okude C., Sawada H., Yamazaki Y., Sugatani J., Miwa M. TRPM6 expression and cell proliferation are up-regulated by phosphorylation of ERK1/2 in renal epithelial cells. Biochemical and Biophysical Research Communications 2008, 369(4):1129-1133.
18. Ikari A., Atomi K., Takiguchi A., Yamazaki Y., Miwa M., Sugatani J. Epidermal growth factor increases claudin-4 expression mediated by Sp1 elevation in MDCK cells. Biochemical and Biophysical Research Communications 2009, 384(3):306-310.
19. Kelepouris E., Agus Z.S. Hypomagnesemia: renal magnesium handling. Seminars in Nephrology 1998, 18(1):58-73.
20. Lajer H., Kristensen M., Hansen H.H., Nielsen S., Frokiaer J., Ostergaard L.F., Christensen S., Daugaard G., Jonassen T.E. Magnesium depletion enhances cisplatin-induced nephrotoxicity. Cancer Chemotherapy and Pharmacology 2005, 56(5):535-542.
21. Li S., Gerrard E.R., Balkovetz D.F. Evidence for ERK1/2 phosphorylation controlling contact inhibition of proliferation in Madin-Darby canine kidney epithelial cells. American Journal of Physiology. Cell Physiology 2004, 287(2):C432-C439.
22. Mene P., Polci R., Festuccia F. Mechanisms of repair after kidney injury. Journal of Nephrology 2003, 16(2):186-195.
23. Mullin J.M., Mcginn M.T. Epidermal growth factor-induced mitogenesis in kidney epithelial cells (LLC-PK1). Cancer Research 1988, 48(17):4886-4891.
24. Pages G., Lenormand P., L'allemain G., Chambard J.C., Meloche S., Pouyssegur J. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proceedings of the National Academy of Sciences of the United States of America 1993, 90(18):8319-8323.
25. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrine Reviews 2001, 22(2):153-183.
26. Pennock S., Wang Z. Stimulation of cell proliferation by endosomal epidermal growth factor receptor as revealed through two distinct phases of signaling. Molecular and Cellular Biology 2003, 23(16):5803-5815.
27. Pere A.K., Lindgren L., Tuomainen P., Krogerus L., Rauhala P., Laakso J., Karppanen H., Vapaatalo H., Ahonen J., Mervaala E.M. Dietary potassium and magnesium supplementation in cyclosporine-induced hypertension and nephrotoxicity. Kidney International 2000, 58(6):2462-2472.
28. Raman M., Chen W., Cobb M.H. Differential regulation and properties of MAPKs. Oncogene 2007, 26(22):3100-3112.
29. Raphael L., Fish J.C. An in vitro model for analyzing the nephrotoxicity of cyclosporine and preservation injury. Transplantation 1987, 43(5):703-708.
30. Romani A. Regulation of magnesium homeostasis and transport in mammalian cells. Archives of Biochemistry and Biophysics 2007, 458(1):90-102.
31. Rubinfeld H., Seger R. The ERK cascade: a prototype of MAPK signaling. Molecular Biotechnology 2005, 31(2):151-174.
32. Runnels L.W., Yue L., Clapham D.E. TRP-PLIK, a bifunctional protein with kinase and ion channel activities. Science 2001, 291(5506):1043-1047.
33. 2+ transporter. Biochemical Journal 2007, 401(2):505-513.
34. Sarica K., Erbagci A., Yagci F., Bakir K., Erturhan S., Ucak R. Limitation of apoptotic changes in renal tubular cell injury induced by hyperoxaluria. Urological Research 2004, 32(4):271-277.
35. Kip1 in normal but not in transformed mammary epithelial cells. Journal of Cellular Physiology 1999, 180(2):245-254.
36. Smith P.L., Buffington D.A., Humes H.D. Kidney epithelial cells. Methods in Enzymology 2006, 419:194-207.
37. Sponsel H.T., Breckon R., Hammond W., Anderson R.J. Mechanisms of recovery from mechanical injury of renal tubular epithelial cells. American Journal of Physiology 1994, 267(2 Pt 2):F257-F264.
38. Touyz R.M., Yao G. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases. Journal of Cellular Physiology 2003, 197(3):326-335.
39. 2+ absorption. Journal of Biological Chemistry 2004, 279(1):19-25.
40. 2+ transporters. Biochemical and Biophysical Research Communications 2003, 306(3):718-724.
41. Xu B., Wilsbacher J.L., Collisson T., Cobb M.H. The N-terminal ERK-binding site of MEK1 is required for efficient feedback phosphorylation by ERK2 in vitro and ERK activation in vivo. Journal of Biological Chemistry 1999, 274(48):34029-34035.
42. Yang Y., Wu Z., Chen Y., Qiao J., Gao M., Yuan J., Nie W., Guo Y. Magnesium deficiency enhances hydrogen peroxide production and oxidative damage in chick embryo hepatocyte in vitro. Biometals 2006, 19(1):71-81.
43. Zebisch A., Czernilofsky A.P., Keri G., Smigelskaite J., Sill H., Troppmair J. Signaling through RAS-RAF-MEK-ERK: from basics to bedside. Current Medicinal Chemistry 2007, 14(5):601-623.